FY26-27 Pediatric Covid-19 Vaccines

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

CDC OFFICE OF ACQUISITION SERVICES

Contract Value

Not provided

Codes & Classification
Solicitation Number

75D30126R73403

NAICS

-

Classification Code

-

Additional Details
Set Aside

None

Place of Performance

Atlanta, Georgia, UNITED STATES

SourceSAM
The Centers for Disease Control and Prevention (CDC), operating under the Department of Health and Human Services, has issued an award notice for the procurement titled "FY26-27 Pediatric Covid-19 Vaccines." This initiative is managed by the CDC Office of Acquisition Services, a federal office based in Atlanta, Georgia. The procurement identifier for this contract is 75D30126R73403, and the opportunity remains active as of the posting date, March 6, 2026. The primary purpose of this procurement is to secure pediatric Covid-19 vaccines for fiscal years 2026 and 2027. The scope of the contract encompasses the acquisition and delivery of vaccines specifically formulated for pediatric populations, supporting the CDC’s ongoing efforts to mitigate the impact of Covid-19 among children. The intended outcome is to ensure a reliable supply of safe and effective vaccines, thereby contributing to public health objectives and safeguarding the well-being of children across the United States. Key requirements and expected deliverables include the provision of pediatric Covid-19 vaccines that meet all relevant regulatory standards and CDC specifications. Contractors are expected to demonstrate the capacity for timely delivery and distribution within the designated place of performance, Atlanta, Georgia. While the notice does not specify additional technical or logistical requirements, it is implicit that compliance with federal procurement and health regulations is mandatory. The contracting entity is the CDC Office of Acquisition Services, which serves as the primary point of contact for this procurement. Interested parties may direct inquiries to Jariya Taylor ([email protected]) or Chad Turner ([email protected]) for further information. The procurement is classified under federal acquisition codes, and the opportunity is listed on SAM.gov under Opportunity ID dce2e49762224496b03e8150d11fd0c8. This award notice does not indicate any set-aside requirements or special considerations, nor does it provide details regarding the procurement type or specific contract terms. Contractors evaluating this opportunity should note the focus on pediatric vaccine supply and the central role of the CDC in contract administration. Elements such as the place of performance, contracting entity, and the overarching public health objectives will remain constant throughout the contract lifecycle. For additional information and updates, contractors are encouraged to consult the official notice at https://sam.gov/opp/dce2e49762224496b03e8150d11fd0c8/view.